The Antibacterial and Anticancer Activity of Marine Actinomycete Strain HP411 Isolated in the Northern Coast of Vietnam

Since the marine environmental conditions are
extremely different from the other ones, marine actinomycetes might
produce novel bioactive compounds. Therefore, actinomycete strains
were screened from marine water and sediment samples collected
from the coastal areas of Northern Vietnam. Ninety-nine
actinomycete strains were obtained on starch-casein agar media by
dilution technique, only seven strains, named HP112, HP12, HP411,
HPN11, HP 11, HPT13 and HPX12, showed significant antibacterial
activity against both gram-positive and gram-negative bacteria
(Bacillus subtilis ATCC 6633, Staphylococcus epidemidis ATCC
12228, Escherichia coli ATCC 11105). Further studies were carried
out with the most active HP411 strain against Candida albicans
ATCC 10231. This strain could grow rapidly on starch casein agar
and other media with high salt containing 7-10% NaCl at 28-30oC.
Spore-chain of HP411 showed an elongated and circular shape with
10 to 30 spores/chain. Identification of the strain was carried out by
employing the taxonomical studies including the 16S rRNA
sequence. Based on phylogenetic and phenotypic evidence it is
proposed that HP411 to be belongs to species Streptomyces
variabilis. The potent of the crude extract of fermentation broth of
HP411 that are effective against wide range of pathogens: both grampositive,
gram-negative and fungi. Further studies revealed that the
crude extract HP411 could obtain the anticancer activity for cancer
cell lines: Hep-G2 (liver cancer cell line); RD (cardiac and skeletal
muscle letters cell line); FL (membrane of the uterus cancer cell line).
However, the actinomycetes from marine ecosystem will be useful
for the discovery of new drugs in the future.

• Huyen T. Pham
• Nhue P. Nguyen
• Tien Q. Phi
• Phuong T. Dang
• Hy G. Le

• Marine actinomycetes
• antibacterial
• anticancer
• Streptomyces variabilis.

[1] A. L. Demain, S. Sánchez S, “Microbial drug discovery: 80 years of
progress”, J. Antibiot. vol. 62, pp 5-16, 2009.
[2] J. Berdy, “Bioactive microbial metabolites”, J. Antibiotechnol.
(Tokyo), vol. 58, pp. 1-26, 2005.
[3] N. S. Egorov, O. Z. Popova, M. V. Bitteeva, V. G. Bulgakova, K.
Gofman “Influence of bacterial metabolites on growth and antibiotic
properities of some actinomycetes”, Mikrobiologia, vol. 29, pp. 269-
275, 1960 (in Russian)
[4] H. P. Fiedler, B. Christina, T. B. Alan, C. W. Alan, G. Michael, P.
Olivier, P. Carsten, H. Gerhard, H, “Marine Actinomycetes as a source
of novel secondary metabolites”, Antonie Leeuwenhock, vol. 87, pp. 37-
42, 2005.
[5] B. N. Ghanem, A. S. Soraya, M. E. Zeinab, A. A. E. Gehan, “Isolation
and enumeration of marine Actinomycetes from seawater and
sediments in Alexandria”, J. Gen. Appl. Microbiol, vol. 46(45), pp.
105-111, 2000.
[6] H. Harada, Y. Kamei, “Selective cytotoxicity of marine algae extracts
to several human leukemic cell lines”, Cytotechnology, vol. 25, pp.
213–219, 1997.
[7] M. Jennifer, “Determination of minimum inhibitory concentration”, J.
Antinicrobial Chemotherapy, vol. 48, Suppl. S1, pp. 5-16, 2001.
[8] M. Kimura, “A Simple Method for Estimating Evolutionary Rates of
Base Substitutions Through Comparative Studies of Nucleotide
Sequences”, J. Molecular Evolution, vol. 16, pp. 111-120, 1980.
[9] K. S. Lam, “Discovery of novel metabolites from marine
actinomycetes”, Curr Opin Microbiol., vol. 12, pp. 245–251, 2006.
[10] K. Likhitwitayawuid, C. K. Angerhofer, G. A. Cordell, J. M. Pezzuto,
N. Ruangrungsri, “Cytotoxic and antimalarial bisbenzylisoquinoline
alkaloids from Stephania erecta”, J. Natural Products, vol. 56, pp. 30-
38, 1993.
[11] T. J. Mincer, P. R. Jensen, C. A. Kauffman, W. Fenical, “Widespread
and persistent populations of a major new marine actinomycte taxon in
ocean sediments”, J. Appl. Environ. Microbiol., vol. 68, pp. 2005-5011,
2002.
[12] G. Mohanraj, T. Sekar, “Antagonistic activity of marine Streptomyces
sp LCJ94 against the shrimp pathogens”, Annals of Biological
Research, vol. 4 (4), pp. 224-227, 2013.
[13] T. F. Molinski, D. S. Dalisay, S. L. Lievens, “Drug development from
marine natural products”, Nat Rev Drug Discov, vol. 8, pp. 69-85,
2009.
[14] K. Moller, T. K. Jensen, S. E. Jorsal, T. D. Leser, B. Cartensen,
Veterinary Microbiology, vol. 62, pp. 59–72, 1998.
[15] M. Nakagawas, Y. Hayakawa, K. Adachi, H. Seto, “A new
depsipeptide antibiotic, variapeptin” Agric. Biol. Chem., vol. 54(3), pp.
791-794, 1990.
[16] D. J. Newman, G. M. Cragg, “Natural Products As Sources of New
Drugs over the 30 Years from 1981 to 2010”, J. Nat. Prod., vol. 75(3),
pp. 311–335, 2012.
[17] C. Olano, C. Méndez, J. A. Salas, “Antitumor compounds from
actinomycetes: from gene clusters to new derivatives by combinatorial
biosynthesis”, J. Nat. Prod. Rep., vol. 26, pp. 628–660, 2009.
[18] N. Saitou, M. Nei, “The Neighbor-joining Method: A New Method for
Reconstructing Phylogenetic Trees, Mol. Biol. Evol., 4: 406-425, 1987.
[19] E. B. Shirling, D. Gottlieb, “Methods for Characterization of
Streptomyces species” Intern. J. Systematic Bacteriology, vol. 16 (3),
pp. 313-340, 1966.
[20] H. D. Tresner, E. J. Backus, “System of color whells for Streptomycete
taxonomy” Appl. Microbiol., vol. 11, pp. 335-338, 1963.
[21] S. T. Williams, M. Goodfellow, G. Alderson, “Genus Streptomyces”.
In: Bergey's Manual of Systematic Bacteriology, (S.T. Williams; M. E.
Sharpe; J. Holt, Edts.) Baltimore, Williams and Wilkins. vol. 4, pp.
2452-2468, 1989.